Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Sina Jostes

A signaling cascade including ARID1A, GADD45B and DUSP1 induces apoptosis and affects the cell cycle of germ cell cancers after romidepsin treatment.

scientific article published on 27 August 2016

BMP Inhibition in Seminomas Initiates Acquisition of Pluripotency via NODAL Signaling Resulting in Reprogramming to an Embryonal Carcinoma

scientific article published on 30 July 2015

Deciphering the molecular effects of romidepsin on germ cell tumours: DHRS2 is involved in cell cycle arrest but not apoptosis or induction of romidepsin effectors

scientific article published on 20 November 2018

Elucidating human male germ cell development by studying germ cell cancer

scientific article

Epigenetic drugs and their molecular targets in testicular germ cell tumours

scientific article published on 01 April 2019

N6-Methyladenosine detected in RNA of testicular germ cell tumors is controlled by METTL3, ALKBH5, YTHDC1/F1/F2, and HNRNPC as writers, erasers, and readers

scientific article published on 23 March 2019

Re-visiting the Protamine-2 locus: deletion, but not haploinsufficiency, renders male mice infertile.

scientific article

SOX2 is essential for in vivo reprogramming of seminoma-like TCam-2 cells to an embryonal carcinoma-like fate

scientific article published on 07 June 2016

Signals and transcription factors for specification of human germ cells.

scientific article published on 29 April 2018

The bromodomain inhibitor JQ1 triggers growth arrest and apoptosis in testicular germ cell tumours in vitro and in vivo

scientific article

The cancer/testis-antigen PRAME supports the pluripotency network and represses somatic and germ cell differentiation programs in seminomas

scientific article published on 21 July 2016

The signal transducer CD24 suppresses the germ cell program and promotes an ectodermal rather than mesodermal cell fate in embryonal carcinomas

scientific article published on 02 August 2021

Xenografting of Cancer Cell Lines for In Vivo Screening of the Therapeutic Potential of HDAC Inhibitors.

scientific article